Holen Sie sich die Stockscreener-App
90.15
1.29%
1.15
Schlusskurs vom Vortag:
$89.00
Offen:
$89.01
24-Stunden-Volumen:
1.40M
Relative Volume:
0.96
Marktkapitalisierung:
$12.07B
Einnahmen:
$2.51B
Nettoeinkommen (Verlust:
$185.56M
KGV:
67.28
EPS:
1.34
Netto-Cashflow:
$517.59M
1W Leistung:
+2.14%
1M Leistung:
-3.55%
6M Leistung:
+49.63%
1J Leistung:
+6.27%
1-Tages-Spanne:
$89.01
$91.00
1-Wochen-Bereich:
$86.06
$91.00
52-Wochen-Spanne:
$51.79
$101.40
Globus Medical Inc Stock (GMED) Company Profile
Firmenname
Globus Medical Inc
Sektor
Branche
Telefon
610-930-1800
Adresse
2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA
Compare GMED vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GMED
Globus Medical Inc
|
90.15 | 11.91B | 2.51B | 185.56M | 517.59M | 1.34 |
|
ABT
Abbott Laboratories
|
113.29 | 195.21B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
377.32 | 141.28B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
98.49 | 123.60B | 35.48B | 4.64B | 5.41B | 3.5856 |
|
BSX
Boston Scientific Corp
|
76.28 | 113.14B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
78.98 | 45.52B | 6.07B | 1.06B | 799.60M | 1.8527 |
Globus Medical Inc Stock (GMED) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-30 | Hochstufung | Needham | Hold → Buy |
| 2026-01-27 | Eingeleitet | TD Cowen | Buy |
| 2025-11-07 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-11-07 | Hochstufung | Truist | Hold → Buy |
| 2025-10-28 | Fortgesetzt | Stifel | Hold |
| 2025-05-27 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-01-10 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-07 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-05-20 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-03-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2023-10-20 | Eingeleitet | ROTH MKM | Buy |
| 2023-09-19 | Hochstufung | Stifel | Hold → Buy |
| 2023-03-30 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2023-02-13 | Herabstufung | BofA Securities | Buy → Underperform |
| 2023-02-10 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-02-10 | Herabstufung | Loop Capital | Buy → Hold |
| 2023-02-10 | Herabstufung | Needham | Buy → Hold |
| 2023-02-10 | Herabstufung | Truist | Buy → Hold |
| 2023-02-10 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-04-13 | Fortgesetzt | Truist | Buy |
| 2022-03-28 | Eingeleitet | Wells Fargo | Overweight |
| 2022-01-04 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-12-13 | Hochstufung | BofA Securities | Underperform → Buy |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-10-29 | Eingeleitet | Loop Capital | Buy |
| 2021-02-18 | Fortgesetzt | Needham | Buy |
| 2020-12-08 | Eingeleitet | Citigroup | Buy |
| 2020-10-20 | Eingeleitet | Stifel | Hold |
| 2020-08-06 | Bestätigt | Needham | Buy |
| 2020-08-06 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2020-07-21 | Eingeleitet | Northland Capital | Market Perform |
| 2020-07-06 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-05-08 | Bestätigt | Needham | Buy |
| 2020-03-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2019-12-12 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2019-08-02 | Bestätigt | Needham | Buy |
| 2019-05-24 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2019-05-03 | Bestätigt | Needham | Buy |
| 2019-02-28 | Hochstufung | UBS | Neutral → Buy |
| 2019-01-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2018-08-02 | Bestätigt | Needham | Buy |
| 2018-06-27 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-06-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-05-03 | Bestätigt | Needham | Buy |
| 2018-04-04 | Hochstufung | Needham | Hold → Buy |
Alle ansehen
Globus Medical Inc Aktie (GMED) Neueste Nachrichten
Impingement Syndrome Market: Future Business Opportunities - openPR.com
Medical Robotics Market to Reach US$ 63.55 Billion by 2033 | CAGR - openPR.com
Globus Medical, Inc. (GMED) Stock Analysis: Strong Revenue Growth and 21.66% Potential Upside Attract Investors - DirectorsTalk Interviews
Is It Time To Reassess Globus Medical (GMED) After Mixed Returns And DCF Upside? - Yahoo Finance
Does Analyst Upgrades After Margin Expansion Change The Bull Case For Globus Medical (GMED)? - Yahoo Finance
Globus Medical to Report Fourth-Quarter and Full-Year 2025 Results February 24 - MyChesCo
Globus Medical Inc. (GMED) Gains Positive Attention Amid Improving Outlook - Finviz
How cyclical is Globus Medical Inc. Class stock compared to rivalsForecast Cut & Community Shared Stock Ideas - mfd.ru
How do insiders feel about Globus Medical Inc.July 2025 Outlook & Precise Swing Trade Entry Alerts - mfd.ru
Why Globus Medical Inc. stock is considered a top pickMarket Weekly Review & Fast Moving Stock Trade Plans - mfd.ru
How cyclical is Globus Medical Inc. (GM0N) stock compared to rivals2025 Valuation Update & Growth Oriented Trade Recommendations - mfd.ru
Is Globus Medical (GMED) Pricing Look Attractive After Recent Sideways Share Performance - Sahm
Globus Medical Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call - marketscreener.com
Globus Medical (GMED) to Report Q4 Results: Wall Street Expects Earnings Growth - Finviz
Versor Investments LP Invests $664,000 in Globus Medical, Inc. $GMED - MarketBeat
Madison Asset Management LLC Sells 58,971 Shares of Globus Medical, Inc. $GMED - MarketBeat
Will Globus Medical Inc. stock maintain dividend yieldWeekly Trade Review & Fast Exit and Entry Strategy Plans - mfd.ru
Globus Medical (GMED) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Globus Medical Reports Record Sales and Strong Growth in 2024 - MSN
Why Globus Medical (GMED) is a Top Growth Stock for the Long-Term - Yahoo Finance
Can Globus Medical Inc. reach all time highs this year - mfd.ru
Candriam S.C.A. Sells 43,909 Shares of Globus Medical, Inc. $GMED - MarketBeat
Globus Medical Inc (NYSE:GMED): A Prime Example of Affordable Growth - ChartMill
Globus Medical (GMED) Valuation Check After Mixed Short Term Returns And 16.6% Undervaluation View - Sahm
Thrivent Financial for Lutherans Sells 194,537 Shares of Globus Medical, Inc. $GMED - MarketBeat
Foresight Group Ltd Liability Partnership Raises Stake in Globus Medical, Inc. $GMED - MarketBeat
How Globus Medical’s Robotics and Digitization Push Will Impact Globus Medical (GMED) Investors - Sahm
New York State Common Retirement Fund Sells 77,412 Shares of Globus Medical, Inc. $GMED - MarketBeat
Here's Why Globus Medical (GMED) is a Strong Value Stock - Yahoo Finance
Globus Medical (GMED) Valuation Check After Mixed Short Term Share Performance - Yahoo Finance
2 Reasons to Watch GMED and 1 to Stay Cautious - Yahoo Finance
Is Globus Medical (GMED) Pricing Fair After The Recent Healthcare Sector Reassessment? - Sahm
Van Berkom & Associates Inc. Purchases 48,906 Shares of Globus Medical, Inc. $GMED - MarketBeat
Globus Medical IncA (NYSE:GMED) Shows Strong Fundamentals and Technical Setup for Growth - ChartMill
Globus Medical, Inc. (GMED): Analyst Consensus and Growth Potential Highlight an 18% Upside - DirectorsTalk Interviews
Zacks Research Lifts Earnings Estimates for Globus Medical - MarketBeat
At US$90.68, Is It Time To Put Globus Medical, Inc. (NYSE:GMED) On Your Watch List? - 富途牛牛
Dip Buying: Will Globus Medical Inc benefit from government policy2025 Risk Factors & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
CEO Change: Can Origin Materials Inc outperform under higher oil prices2025 AllTime Highs & Growth Focused Entry Point Reports - baoquankhu1.vn
Assessing Globus Medical (GMED) Valuation After Investor Letter Highlights Reaccelerating Spine Growth And Integration Progress - Sahm
Needham upgrades Globus Medical stock to Buy on margin expansion By Investing.com - Investing.com Canada
Needham Upgrades Globus Medical to Buy From Hold, Sets $112 Price Target - marketscreener.com
The Analyst Verdict: Globus Medical In The Eyes Of 13 Experts - Benzinga
This Southwest Airlines Analyst Turns Bullish; Here Are Top 3 Upgrades For Friday - Benzinga
Analyst Upgrade: Needham Upgrades GMED to 'Buy' Rating | GMED St - GuruFocus
Globus Medical (NYSE:GMED) Upgraded by Needham & Company LLC to "Buy" Rating - MarketBeat
Needham Upgrades Globus Medical (GMED) - Nasdaq
TD Cowen Upgrades Globus Medical (NYSE:GMED) to "Strong-Buy" - MarketBeat
Cambiar Investors LLC Sells 55,919 Shares of Globus Medical, Inc. $GMED - MarketBeat
Here's Why Globus Medical (GMED) is a Strong Momentum Stock - sharewise.com
Y Intercept Hong Kong Ltd Cuts Position in Globus Medical, Inc. $GMED - MarketBeat
Finanzdaten der Globus Medical Inc-Aktie (GMED)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.13%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):